Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical‐controlled, multicenter, double‐blind study

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1088-1098

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities

By Karikas George   Schulpis Kleopatra   Bartzeliotou Anastasia   Regoutas Spyros   Thanopoulou Christina   Papaevangelou Vassiliki   Giannoulia-Karantana Aglaia   Papassotiriou Ioannis   Fytou-Pallikari Athena  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 1, 2009-02 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study

By  

EPILEPSIA, Vol. 56, Iss. 12, 2015-12 ,pp. : 1921-1930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of clobazam monotherapy in three cases of symptomatic localization-related epilepsy in children

By Iwasaki Toshiyuki   Nonoda Yutaka   Takei Kenji   Hosoda Nozomi   Ishii Masahiro  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 589-593

Future Medicine

Access to resources Recommend Favorite

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite